SCSA Diagnostics
- Company typePrivate
- Founded2001
- HeadquartersBrookings, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
SCSA Diagnostics firmographics
Firmographics- Name
- SCSA Diagnostics
- Legal name
- SCSA Diagnostics, Inc.
- Website
- https://scsadiagnostics.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
SCSA Diagnostics industry classification
Industry- Product category
- Male Fertility Diagnostics
- NAICS
- Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI)
- akta.pro secondary industries
- Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection) (HLAHAOAF), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)
Keywords
Where SCSA Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Brookings
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
SCSA Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Laboratory Testing Fee: Core revenue from SCSA sperm DNA fragmentation testing. Patients/clinics pay a laboratory fee that includes the clinical report. Fee varies by market: $500 for US patients, $500+ for international patients.
- Shipping and Handling: Fees for pre-cooled dry shippers and round-trip Federal Express shipping. $150 for continental US, approximately $250 for Canada, with varying costs for other destinations.
- Insurance Billing: When ordered with physician referral, patients can submit insurance claims using CPT/Procedure Code 88182 for potential reimbursement.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Patient Direct-Order Testing (with Doctor Referral) - U.S. |
| One time/ perpetual license | Pay-as-you-go | Patient Direct-Order Testing (without Doctor Referral) - U.S. |
| One time/ perpetual license | Pay-as-you-go | International Patients |
| One time/ perpetual license | Pay-as-you-go | Clinic/Lab Testing |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
SCSA Diagnostics product offering
Product offeringCore offering
SCSA Diagnostics provides the SCSA (Sperm Chromatin Structure Assay) test, a clinical laboratory diagnostic that measures sperm DNA fragmentation using flow cytometry and acridine orange staining. Each test delivers a DNA Fragmentation Index (DFI) and High DNA Stainability (HDS) value derived from 5,000 sperm analyzed per sample, producing a clinical report with statistical pregnancy outcome predictions for trying-to-conceive couples and their physicians.
Product overview
SCSA Diagnostics offers a single unified diagnostic testing service centered on the SCSA (Sperm Chromatin Structure Assay) test, the original Gold Standard sperm DNA fragmentation screening tool. The core SCSA test uses flow cytometry technology with proprietary SCSAsoft software to analyze sperm DNA integrity, measuring DNA Fragmentation Index (DFI) and High DNA Stainability (HDS). Patients can order the test with or without physician referral, with home collection kits available for discreet sample collection shipped via Federal Express. Results are delivered as clinical reports to physicians and patients, providing statistical pregnancy outcome predictions.
Differentiator
Problem solved
Functional benefit
Brands
- SCSAsoft: Proprietary software used by SCSA Diagnostics to calculate DNA Fragmentation Index (DFI) and High DNA Stainability (HDS) results from flow cytometry data.
Products and services
- SCSA Test (Sperm Chromatin Structure Assay) The original and Gold Standard sperm DNA fragmentation screening test, performed via flow cytometry with acridine orange staining and proprietary SCSAsoft software. Delivers DNA Fragmentation Index (DFI) and High DNA Stainability (HDS) values for trying-to-conceive couples, their physicians, fertility clinics, and andrology labs to guide fertility treatment decisions.
Quantifiable outcome
- Clinical threshold: >25% DFI significantly reduces pregnancy probability
- +4 more outcomes
Companies that use SCSA Diagnostics
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles2 records
SCSA Diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
SCSA Diagnostics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Federal ExpresscoreFederal Express is the exclusive shipping partner for transporting temperature-controlled dry shippers containing semen samples. FedEx handles 2-day shipping of biological samples from patient homes and clinics to SCSA Diagnostics Brookings laboratory. SCSA provides prepaid return shipping labels for patients.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
SCSA Diagnostics competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
SCSA Diagnostics social profiles
Digital presenceSCSA Diagnostics compliance and trust
Trust signalCompliance2 records
SCSA Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
SCSA Diagnostics leadership team
Management profileNumber of profiles
Profiles3 records
SCSA Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SCSA Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SCSA Diagnostics
What does SCSA Diagnostics do?
SCSA Diagnostics provides the SCSA (Sperm Chromatin Structure Assay) test, a clinical laboratory diagnostic that measures sperm DNA fragmentation using flow cytometry and acridine orange staining. Each test delivers a DNA Fragmentation Index (DFI) and High DNA Stainability (HDS) value derived from 5,000 sperm analyzed per sample, producing a clinical report with statistical pregnancy outcome predictions for trying-to-conceive couples and their physicians.
Is SCSA Diagnostics a public or private company?
SCSA Diagnostics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was SCSA Diagnostics founded?
SCSA Diagnostics was founded in 2001. It employs 1 to 10 people.
Where is SCSA Diagnostics based?
SCSA Diagnostics is headquartered in Brookings, United States, in the North America region.
How does SCSA Diagnostics make money?
Three revenue lines are on record. Laboratory Testing Fee is the primary driver. The others are shipping and Handling and insurance Billing.
Does SCSA Diagnostics have an API?
No public API is recorded for SCSA Diagnostics.
What industry is SCSA Diagnostics in?
SCSA Diagnostics's product category is Male Fertility Diagnostics. Its primary akta.pro industry code is HLAHAAAI, Genetic, Cytogenetic & Prenatal Screening IVD, with a secondary code of HLAHAOAF, Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection). Its NAICS code is 621511 and its SIC code is 2835.